Valuation Torrent Pharmaceuticals Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. 07:05:10 2026-09-18 EDT			5-day change	1st Jan Change
4,840.00 ^INR	-0.72%		-2.53%	+25.71%

09-08	India's Torrent Gas files updated IPO papers	RE
07-30	Torrent Pharmaceuticals Limited, Q1 2027 Earnings Call, Jul 30, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	473,197	520,309	880,347	1,094,736	1,428,460	1,827,382	-	-
Change	-	9.96%	69.2%	24.35%	30.48%	27.93%	-	-
Enterprise Value (EV) ¹	508,027	566,719	910,767	1,119,846	1,564,790	1,949,386	1,920,984	1,885,442
Change	-	11.55%	60.71%	22.96%	39.73%	24.58%	-1.46%	-1.85%
P/E	60.9x	57.4x	53.1x	57.3x	66x	71.4x	51.7x	41.6x
PBR	7.95x	8.4x	12.8x	14.4x	17x	12.8x	11x	9.44x
PEG	-	3.4x	0.6x	3.7x	5x	13.39x	1.4x	1.7x
Capitalization / Revenue	5.56x	5.41x	8.21x	9.51x	10.2x	9.23x	8.2x	7.32x
EV / Revenue	5.97x	5.89x	8.49x	9.72x	11.2x	9.84x	8.62x	7.55x
EV / EBITDA	20.9x	19.9x	27x	30.1x	34.3x	29.3x	24.7x	21.2x
EV / EBIT	28.7x	26.5x	34.4x	38.3x	45.5x	44.6x	35.5x	29.1x
EV / FCF	31.8x	31.6x	32.1x	56.7x	66.7x	49.6x	35.2x	31.1x
FCF Yield	3.15%	3.17%	3.11%	1.76%	1.5%	2.02%	2.84%	3.21%
Dividend per Share ²	16.5	22	28	32	38	32.7	38.18	46.78
Rate of return	1.18%	1.43%	1.08%	0.99%	0.9%	0.68%	0.79%	0.97%
EPS ²	22.96	26.79	48.94	56.47	63.92	67.33	92.92	115.4
Distribution rate	71.8%	82.1%	57.2%	56.7%	59.4%	48.6%	41.1%	40.5%
Net sales ¹	85,080	96,200	107,280	115,160	139,800	198,060	222,820	249,657
EBITDA ¹	24,310	28,420	33,680	37,210	45,590	66,600	77,800	89,023
EBIT ¹	17,690	21,350	26,480	29,260	34,400	43,718	54,154	64,773
Net income ¹	7,770	12,450	16,560	19,110	21,630	24,722	34,254	43,639
Net Debt ¹	34,830	46,410	30,420	25,110	136,330	122,003	93,601	58,060
Reference price ²	1,398.15	1,537.35	2,601.15	3,234.60	4,220.65	4,804.25	4,804.25	4,804.25
Nbr of stocks (in thousands)	338,445	338,445	338,445	338,445	338,445	380,368	-	-
Announcement Date	5/25/22	5/30/23	5/24/24	5/20/25	5/22/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.77x	11.91x	24.15x	0.6%	1,027B
JOHNSON & JOHNSON	30.06x	6.68x	18.71x	1.99%	651B
ABBVIE INC.	33.39x	7.81x	16.15x	2.6%	467B
ROCHE HOLDING AG	19.57x	4.78x	11.84x	2.77%	350B
NOVARTIS AG	19.88x	5.19x	12.87x	3.09%	268B
ASTRAZENECA PLC	21.24x	4.38x	12.5x	2.01%	257B
AMGEN INC.	24.06x	6.34x	11.29x	2.66%	205B
NOVO NORDISK A/S	12.43x	4.52x	9.45x	4.04%	190B
GILEAD SCIENCES, INC.	-45.64x	6.64x	25.94x	2.18%	187B
Average	16.42x	6.47x	15.88x	2.44%	400.23B
Weighted average by Cap.	23.65x	7.72x	17.85x	1.99%